MiNK Therapeutics, Inc. entered into a stock purchase agreement for issuance of 4,640,000 common shares at a price of $1.25 per share for gross proceeds of $5,800,000 on May 13, 2024. The transaction is expected to close on May 14, 2024, subject to customary closing conditions.